59 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
in the valuation of the CVR liability; inputs used in the Black-Scholes model for stock-based compensation expense; estimated future cash flows used in calculating … in the Black-Scholes model for stock-based compensation expense; estimated future cash flows used in calculating the impairment ofright-of-use
lease assets
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
of success, and timing of estimated cash flows in the valuation of the CVR liability; inputs used in the Black-Scholes model for stock-based … of estimated cash flows in the valuation of the CVR liability; inputs used in the Black-Scholes model for stock-based compensation expense; estimated
POS AM
knbst6 qi
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
8-K
EX-99.2
o4kei jrjilmvj1
15 Nov 23
Other Events
5:14pm
8-K
EX-99.1
t0tiwkg vxfdgoi
24 Oct 23
Regulation FD Disclosure
9:00am
8-K
EX-99.1
gt5rwz
10 Oct 23
Report of Independent Registered Public Accounting Firm
12:00am